Xeriant, Inc.: Form 10-K for the period ended Jun 30, 2024
Filed with the SEC on Oct 8, 2024 and accepted by EDGAR at Oct 8, 2024, 09:19 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Research and development | 12 months2023-07-01 to 2024-06-30 | $196.4k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2023-07-01 to 2024-06-30 | −$1.9m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2023-07-01 to 2024-06-30 | $1.2m | us-gaap:InterestExpense |
| Net income | 12 months2023-07-01 to 2024-06-30 | −$3.1m | us-gaap:NetIncomeLoss |
| Operating cash flow | 12 months2023-07-01 to 2024-06-30 | −$1.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2023-07-01 to 2024-06-30 | $0 | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Current assets | At period end2024-06-30 | $664.2k | us-gaap:AssetsCurrent |
| Total assets | At period end2024-06-30 | $713.0k | us-gaap:Assets |
| Current liabilities | At period end2024-06-30 | $9.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-06-30 | $9.3m | us-gaap:Liabilities |
| Shareholders' equity | At period end2024-06-30 | −$5.8m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001477932-24-006252. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.